Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression.
Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression. — المؤلف: Isshiki, Takuma — Case reports in oncology
- المؤلف
- Isshiki, Takuma
- النشر
- Case reports in oncology
- الوصف
- 688-692 p.